Malaria Vaccine Development Program
Global Problem
There are more than 300-500 million
episodes of malaria each year, causing more than 2 million
deaths, mostly in children. Non-fatal malaria imposes an enormous
economic burden of illness, which has a major impact on the
affected communities. Malaria costs more than $1.7 billion
each year in medical care and lost productivity. However,
available methods to prevent and treat malaria are inadequate:
the mosquitoes that transmit the disease have become resistant
to insecticides and the parasites that cause malaria have
become resistant to the treatment drugs. New technologies
are urgently needed. Economic analyses have concluded that
the benefits from an effective malaria vaccine would far outweigh
the anticipated costs of research and development and continuing
implementation.
The Opportunity
USAID Accomplishments
Current Focus
|